Filgastrim efficacy in treatment of cytostatic myelossuppressions for breast cancer patients
Автор: Khrichkova T.Yu., Goldberg V.E., Zhdanov V.V., Matyash M.G., Vysotskaya V.V., Simolina E.I., Shatalova V.A., Popova N.O., Miroshnichenko L.A.
Журнал: Сибирский онкологический журнал @siboncoj
Рубрика: Клинические исследования
Статья в выпуске: 1 (25), 2008 года.
Бесплатный доступ
Hematologic effects of Filgastrim (granulocyte colony-stimulating factor) were studied for stage III-IV breast cancer patients who simultaneously received chemotherapy with adriablastin + taxofer. Filgastrim administration resulted in stimulation of bone marrow granulocytopoesis suppressed by cytostatic drugs on the level of committed progenitor cells, morphologically differentiated elements of bone marrow and peripheral blood.
Breast cancer, chemotherapy, myelosuppression, filgastrim (neupogen)
Короткий адрес: https://sciup.org/14056739
IDR: 14056739
